Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Alpine Psychiatry Offers Comprehensive Mental Health Services Across Pennsylvania
EIN Presswire
Clinician-owned practice provides in-person and virtual psychiatric care and therapy to patients across Pennsylvania, New Jersey, and New York. KING OF PRUSSIA, PA, UNITED STATES, July 16, 2026 /EINPresswire.com/ -- Alpine Psychiatry, a...
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
GlobeNewswire, Inc.
New York, USA, July 16, 2026 (GLOBE NEWSWIRE) -- Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight The Parkinson's disease clinical trial analysis report delivers important...
Airengy and Nobian to jointly explore 2.5 GWh Compressed Air Energy Power Plant (CAPP) in Denmark
EIN Presswire
The intended compressed air power plant in Denmark adds to Airengy's previous compressed-air power plant projects in England, Romania, and Germany.
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
GlobeNewswire, Inc.
Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 Preclinical data for sutacimig in Factor VII deficiency (FVIID) demonstrate restoration of...
Elevara Medicines Appoints Biotech Veteran as CEO
GlobeNewswire, Inc.
Elevara Medicines Appoints Biotech Veteran as CEO Founder and former CEO of Nasdaq listed IO Biotech, Dr Mai-Britt Zocca appointed CEO Experienced chief executive with extensive operational and strategic experience in the international...
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
GlobeNewswire, Inc.
Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark, July 13, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
GlobeNewswire, Inc.
HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated partial...
South Korea and Denmark Partner on AI-Enabled Healthy Ageing and Dementia Prevention
EIN Presswire
South Korean and Danish partners develop AI-enabled prevention solutions supporting healthy ageing, independence and sustainable welfare systems.
Smartpatient and Novo Nordisk Set a New Standard for Connected Care for People with Metabolic Diseases in Germany
EIN Presswire
MUNICH, GERMANY, July 8, 2026 /EINPresswire.com/ -- Smartpatient and Novo Nordisk have launched a new digital support program for people living with Type 2 diabetes in Germany.
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
GlobeNewswire, Inc.
Company announcement No. 31 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Potato Protein Market to Reach US$461.2 Mn by 2033 Driven by Plant-Based Nutrition
EIN Presswire
The global potato protein market set to reach US$296.8 Mn in 2026 and US$461.2 Mn by 2033, growing at a CAGR of 6.5% during 2026–2033 forecast period LONDON, ENGLAND, UNITED KINGDOM, July 6, 2026 /EINPresswire.com/ -- The global potato protein...
Leading Global Voices Call for Renewed Solidarity in Support of the Iranian People
Freedom House
WASHINGTON—Leading democracy organizations and experts issued a joint statement, released today by Freedom House, to emphasize that the future of Iran should belong to its people.
IdealofMeD Awarded Best Beard Transplant Clinic
EIN Presswire
Already holding global recognition as one of the world’s best hair restoration providers, IdealofMeD has now been named Worlds Best Beard Transplant Clinic FL, UNITED STATES, July 2, 2026 /EINPresswire.com/ -- IdealofMeD Awarded Best Beard...
ISS extends and expands partnership with public healthcare provider in Southern Europe
GlobeNewswire, Inc.
Copenhagen, July 02, 2026 (GLOBE NEWSWIRE) -- Under the agreement, ISS will expand its current cleaning services to include additional services while also increasing the scope of cleaning across the customer's site.
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
GlobeNewswire, Inc.
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (“LNP”) technology against Pfizer and BioNTech Received approximately $178M from Moderna as...
Single-Cell Protein Market to Reach US$ 21.4 Bn by 2033 Driven by Sustainable Nutrition
EIN Presswire
The global single-cell protein market is set to grow from US$12.1Bn in 2026 to US$21.4Bn by 2033, expanding at a steady CAGR of 8.4% driven by demands LONDON, ENGLAND, UNITED KINGDOM, July 2, 2026 /EINPresswire.com/ -- The global single-cell...
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
GlobeNewswire, Inc.
Company announcement – No. 30 / 2026 Total number of shares and voting rights in Zealand Pharma as of June 30, 2026 Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S (“Zealand Pharma” or "the Company") (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
GlobeNewswire, Inc.
Company announcement No. 29 / 2026 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
GlobeNewswire, Inc.
SEATTLE, June 30, 2026 (GLOBE NEWSWIRE) -- Drug developers have a new, optimized option for U.S.-based manufacturing, as AGC Biologics enters a strategic partnership with Pyramid Pharma Services.
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
GlobeNewswire, Inc.
Company announcement No. 28 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 26, 2026) Copenhagen, Denmark, June 29, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.